← Browse by Condition
Medical Condition

pancreatic adenocarcinoma non resectable

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07481383 Phase 1
Recruiting

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

Enrollment
12 pts
Location
United States
Sponsor
Continuity Biosciences, LLC
View Trial →